Winter Has Come: Big Pharma Cold And Cough Sales Drop By Half Following New China Policy
This article was originally published in PharmAsia News
Executive Summary
Multinational cold and cough OTC products have suffered a serious setback in China, as government restricts usage of drugs containing pseudoephedrine.